<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39252682</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1598-6357</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>35</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of Korean medical science</Title><ISOAbbreviation>J Korean Med Sci</ISOAbbreviation></Journal><ArticleTitle>Viral, Immunologic, and Laboratory Parameters in Patients With and Without Post-Acute Sequelae of SARS-CoV-2 Infection (PASC).</ArticleTitle><Pagination><StartPage>e237</StartPage><MedlinePgn>e237</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3346/jkms.2024.39.e237</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The pathophysiological mechanisms underlying the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC) are not well understood. Our study aimed to investigate various aspects of theses mechanisms, including viral persistence, immunological responses, and laboratory parameters in patients with and without PASC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We prospectively enrolled adults aged &#x2265; 18 years diagnosed with coronavirus disease 2019 (COVID-19) between August 2022 and July 2023. Blood samples were collected at three time-points: within one month of diagnosis (acute phase) and at 1 month, and 3 months post-diagnosis. Following a recent well-designed definition of PASC, PASC patients were defined as those with a questionnaire-based PASC score &#x2265; 12 persisting for at least 4 weeks after the initial COVID-19 diagnosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 57 eligible COVID-19 patients, 29 (51%) had PASC, and 28 (49%) did not. The PASC group had significantly higher nucleocapsid protein (NP) antigenemia 3 months after COVID-19 diagnosis (<i>P</i> = 0.022). Furthermore, several cytokines, including IL-2, IL-17A, VEGF, RANTES, sCD40L, IP-10, I-TAC, and granzyme A, were markedly elevated in the PASC group 1 and/or 3 month(s) after COVID-19 diagnosis. In contrast, the median values of several serological markers, including thyroid markers, autoimmune indicators, and stress-related hormones, were within the normal range.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Levels of NP antigen and of various cytokines involved in immune responses become significantly elevated over time after COVID-19 diagnosis in PASC patients compared to non-PASC patients. This suggests that PASC is associated with prolonged immune dysregulation resulting from heightened antigenic stimulation.</AbstractText><CopyrightInformation>&#xa9; 2024 The Korean Academy of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ra</LastName><ForeName>Sang Hyun</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0001-8426-3331</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chang</LastName><ForeName>Euijin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7417-0318</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kwon</LastName><ForeName>Ji-Soo</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-6945-6100</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Yeun</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0001-6955-6427</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>JuYeon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0000-8018-7036</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Woori</ForeName><Initials>W</Initials><Identifier Source="ORCID">0009-0006-4705-0576</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Choi Young</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-3773-3297</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Hyeon Mu</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0009-0003-0132-5261</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Seongman</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6375-3657</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4333-3270</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Jae</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-5489-8608</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Yong Pil</ForeName><Initials>YP</Initials><Identifier Source="ORCID">0000-0003-1672-3185</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang-Oh</ForeName><Initials>SO</Initials><Identifier Source="ORCID">0000-0003-1381-8787</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sang-Ho</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-4972-4531</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yang Soo</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0002-6785-8824</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Keun Hwa</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0002-2259-2751</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Hanyang University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sung-Han</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-6596-8253</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. kimsunghanmd@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HD22C2045</GrantID><Agency>Korea Health Industry Development Institute</Agency><Country>Republic of Korea</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Korean Med Sci</MedlineTA><NlmUniqueID>8703518</NlmUniqueID><ISSNLinking>1011-8934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086462">Coronavirus Nucleocapsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000705834">nucleocapsid phosphoprotein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Korean Med Sci. 2024 Oct 07;39(38):e304. doi: 10.3346/jkms.2024.39.e304</RefSource><PMID Version="1">39376194</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086462" MajorTopicYN="N">Coronavirus Nucleocapsid Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cytokine</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Nucleocapsid Protein (NP)</Keyword><Keyword MajorTopicYN="N">Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)</Keyword></KeywordList><CoiStatement>The authors have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39252682</ArticleId><ArticleId IdType="pmc">PMC11387074</ArticleId><ArticleId IdType="doi">10.3346/jkms.2024.39.e237</ArticleId><ArticleId IdType="pii">39.e237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller MC, Liang CJ, Marques AR, Chung JY, Shanbhag SM, Fontana JR, et al. A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann Intern Med. 2022;175(7):969&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76(3):e487&#x2013;e490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann Neurol. 2022;91(6):772&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3(6):100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Ruiz J, Lomel&#xed;n-Gasc&#xf3;n J, Lira Luna J, Vargas-Castro AS, P&#xe9;rez-Fragoso A, Nu&#xf1;ez-Aguirre M, et al. Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study. Infect Dis (Lond) 2023;55(4):243&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">36637466</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934&#x2013;1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon JS, Kim JY, Kim MC, Park SY, Kim BN, Bae S, et al. Factors of severity in patients with COVID-19: cytokine/chemokine concentrations, viral load, and antibody responses. Am J Trop Med Hyg. 2020;103(6):2412&#x2013;2418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7695090</ArticleId><ArticleId IdType="pubmed">33124544</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005;47(4):458&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">16161804</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkerke HP, Damhorst GL, Graciaa DS, McLendon K, O&#x2019;Sick W, Robichaux C, et al. Nucleocapsid antigenemia is a marker of acute SARS-CoV-2 infection. J Infect Dis. 2022;226(9):1577&#x2013;1587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384592</ArticleId><ArticleId IdType="pubmed">35877413</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YJ, Seo YB, Seo JW, Lee J, Nham E, Seong H, et al. Effectiveness of antiviral therapy on long COVID: a systematic review and meta-analysis. J Clin Med. 2023;12(23):7375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10707593</ArticleId><ArticleId IdType="pubmed">38068427</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G, Melia CE, Snijder EJ, B&#xe1;rcena M. Double-membrane vesicles as platforms for viral replication. Trends Microbiol. 2020;28(12):1022&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289118</ArticleId><ArticleId IdType="pubmed">32536523</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J, Reincke SM, Pr&#xfc;ss H. Do cross-reactive antibodies cause neuropathology in COVID-19? Nat Rev Immunol. 2020;20(11):645&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537977</ArticleId><ArticleId IdType="pubmed">33024283</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>